CMND
Clearmind Medicine Inc (CMND)
Healthcare • NASDAQ • $0.55-2.08%
- Symbol
- CMND
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $0.55
- Daily Change
- -2.08%
- Market Cap
- $5.61M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $52.40
- 52W Low
- $0.52
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- -1.12
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabol…
Company websiteResearch CMND on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.